# PD-1 Antibody Expressing CAR-T Cells for EGFR Family Member Positive Advanced Solid Tumor

> **NCT02873390** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Ningbo Cancer Hospital** · enrollment: 20 (estimated)

## Conditions studied

- PD-1 Antibody
- CAR-T Cells
- Advanced Malignancies

## Interventions

- **BIOLOGICAL:** HerinCAR-PD1 cells

## Key facts

- **NCT ID:** NCT02873390
- **Lead sponsor:** Ningbo Cancer Hospital
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-08
- **Primary completion:** 2018-03
- **Final completion:** 2018-07
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2016-10-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02873390

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02873390, "PD-1 Antibody Expressing CAR-T Cells for EGFR Family Member Positive Advanced Solid Tumor". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02873390. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*